成人COVID-19急诊就诊者细菌学检查诊断率及重症结局预测因素
本研究为PredictED大型观察性队列的子研究,纳入2020年3-4月荷兰Haga教学医院急诊科142例SARS-CoV-2 PCR阳性成人患者。主要结局细菌合并感染发生率为2/142(1.4%),血培养无病原菌生长,6.3%污染。41例(29%)发生重症病程(ICU入住和/或30天死亡),24例(17%)30天内死亡。降钙素原和PSI预测重症的AUC分别为0.76(95%CI 0.68-0.84)和0.72(0.63-0.81),优于CRP、铁蛋白和淋巴细胞计数。血培养在COVID-19急诊评估中价值有限,降钙素原和PSI有助于识别重症风险患者。
要点
- 142例SARS-CoV-2阳性急诊患者中细菌合并感染仅2例(1.4%),血培养无病原菌生长,6.3%污染,不支持常规血培养。
- 降钙素原预测重症病程AUC为0.76(95%CI 0.68-0.84),PSI为0.72(0.63-0.81),两者为最有希望的预测工具。
- CRP(AUC 0.70,95%CI 0.61-0.79)、铁蛋白(0.62,0.51-0.74)、淋巴细胞计数(0.62,0.51-0.72)预测能力较弱。
- 重症病程(ICU入住和/或30天死亡)发生于41/142(29%),30天死亡24/142(17%)。
- 就诊时症状中位持续时间8天,提示纳入人群多为病程第1周余就诊者。
适用人群与场景
- 荷兰Haga教学医院急诊科就诊、因疑诊感染行血培养的成人患者中,SARS-CoV-2 PCR阳性者(2020年3-4月)。
- 子研究纳入PredictED队列中所有SARS-CoV-2 PCR阳性成人患者,共142例,就诊时症状中位持续8天。
诊断标准与关键阈值
- 重症病程定义:ICU入住和/或30天死亡。
- 细菌合并感染为主要结局,原文未给出具体诊断标准。
- 预测指标包括降钙素原、CRP、铁蛋白、淋巴细胞计数和PSI评分,原文未给出各指标的具体阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:大型观察性队列研究(PredictED)的子研究,单中心(荷兰Haga教学医院),纳入2020年3-4月142例急诊SARS-CoV-2 PCR阳性成人患者。
- 细菌合并感染发生率2/142(1.4%);血培养无病原菌生长,6.3%污染。
- 41/142(29%)发生重症病程(ICU入住和/或30天死亡),24/142(17%)30天内死亡。
- 降钙素原预测重症AUC 0.76(95%CI 0.68-0.84);CRP 0.70(0.61-0.79);铁蛋白0.62(0.51-0.74);淋巴细胞计数0.62(0.51-0.72);PSI 0.72(0.63-0.81)。
证据类型、等级与局限
- 证据类型:观察性队列研究的子研究(非RCT),单中心,样本量142例,2020年3-4月数据。
- 局限:单中心、样本量小、回顾性分析特征、特定早期疫情时期人群,原文未提及其他局限。
对床旁实践的改变
- COVID-19急诊患者血培养致病菌检出极低(0/142),常规血培养的临床价值有限,可减少不必要的血培养。
- 降钙素原和PSI可用于急诊识别COVID-19重症风险患者,但原文未给出具体决策阈值,不能据此设定启动阈值。
- CRP、铁蛋白、淋巴细胞计数对重症预测能力较弱,不宜单独用于分诊决策。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Guidelines recommend maximal efforts to obtain blood and sputum cultures in patients with COVID-19, as bacterial coinfection is associated with worse outcomes. The aim of this study was to evaluate the yield of bacteriological tests, including blood and sputum cultures, and the association of multiple biomarkers and the Pneumonia Severity Index (PSI) with clinical and microbiological outcomes in patients with COVID-19 presenting to the emergency department (ED).
METHODS: This is a substudy of a large observational cohort study (PredictED study). The PredictED included adult patients from whom a blood culture was drawn at the ED of Haga Teaching Hospital, The Netherlands. For this substudy, all patients who tested positive for SARS-CoV-2 by PCR in March and April 2020 were included. The primary outcome was the incidence of bacterial coinfection. We used logistic regression analysis for associations of procalcitonin, C reactive protein (CRP), ferritin, lymphocyte count and PSI score with a severe disease course, defined as intensive care unit admission and/or 30-day mortality. The area under the receiver operating characteristics curve (AUC) quantified the discriminatory performance.
RESULTS: We included 142 SARS-CoV-2 positive patients. On presentation, the median duration of symptoms was 8 days. 41 (29%) patients had a severe disease course and 24 (17%) died within 30 days. The incidence of bacterial coinfection was 2/142 (1.4%). None of the blood cultures showed pathogen growth while 6.3% was contaminated. The AUCs for predicting severe disease were 0.76 (95% CI 0.68 to 0.84), 0.70 (0.61 to 0.79), 0.62 (0.51 to 0.74), 0.62 (0.51 to 0.72) and 0.72 (0.63 to 0.81) for procalcitonin, CRP, ferritin, lymphocyte count and PSI score, respectively.
CONCLUSION: Blood cultures appear to have limited value while procalcitonin and the PSI appear to be promising tools in helping physicians identify patients at risk for severe disease course in COVID-19 at presentation to the ED.
参考来源
- Kaal A, Snel L, Dane M, et al. Diagnostic yield of bacteriological tests and predictors of severe outcome in adult patients with COVID-19 presenting to the emergency department. Emerg Med J. 2021. PMID: 34289966. doi:10.1136/emermed-2020-211027
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。